Biopep Is Granted Two Additional US Patents
The Company has just recently been granted two additional US patents: The application of LSE to diabetes treatment, Application No. 13/624,856 Anti-oxidant properties of LSE. Application No. 13/624,860
The Company has just recently been granted two additional US patents: The application of LSE to diabetes treatment, Application No. 13/624,856 Anti-oxidant properties of LSE. Application No. 13/624,860
Dr. Nayaz Ahmed, of San Diego, California, a PhD in Organic Chemistry, a pharmaceutical development scientist with experience in implementing and maintaining scientifically sound comprehensive systems to ensure filing and approval process for IND, NDA, BLA and ANDA products adhere to FDA and Health Canada guidelines, has officially joined our Scientific Advisory Board. He is […]
In addition to our existing patent that allows Biopep to use LSE on all types of cancers, the US Patent Office has just issued a second patent to Biopep protecting our unique method of LSE extraction.